EVIDENCE · MICROSCOPIA NETWORK
Explore outputs from research governed by microscopIA or conducted in collaboration. Each record distinguishes scientific responsibility, affiliations, editorial status and source.
“Governed” identifies projects under microscopIA scientific responsibility and approval processes. “Collaboration” identifies work conducted jointly. An author’s affiliation alone does not make an output a governed project.
A selection of our work. Some projects in progress or peer review are not disclosed under confidentiality agreements with their investigators.
A percentage describes a proportion within the stated group. A risk ratio compares two risks: 1 means equal risks; 2 means twice the risk in the stated comparison, not twice the number of patients. Association alone does not establish causation.
The estimated number of people treated for one additional benefit over a specified period and comparator. It depends on baseline risk and uncertainty.
Read the BMJ methods article ↗A quality-adjusted life-year (QALY) combines length and quality of life. Net monetary benefit (NMB) values health gains at the study’s stated threshold, then subtracts costs. A cost-effectiveness probability summarizes model uncertainty; it is not the probability that a patient improves.
Read about cost-effectiveness uncertainty ↗Read the group order, units, study design and follow-up alongside each estimate. Counts remain whole numbers; monetary and percentage estimates use two decimal places where supported. See the source for confidence intervals and limitations.
Pediatric trauma and reconstructive surgery
This case report describes the staged orthoplastic reconstruction of an 8-cm open Achilles tendon defect following crush trauma in a 7-year-old child, focusing on the reconstructive strategy used to restore tendon continuity and soft-tissue coverage after severe injury.
Retinopathy of prematurity and health economics
This study evaluates the cost-effectiveness of topical ketorolac and nepafenac prophylaxis for early-stage retinopathy of prematurity using multicenter real-world clinical and economic data from Colombia.
48 ketorolac, 98 nepafenac and 46 historical surveillance comparators.
Retinopathy of prematurity
This study evaluates real-world clinical outcomes associated with topical ketorolac and nepafenac prophylaxis for early-stage retinopathy of prematurity across a multicenter care network in Colombia.
48 ketorolac, 98 nepafenac and 46 historical surveillance comparators.
Observational estimate, not a randomized efficacy result.
Transplantation and health-system access
This study evaluates graft-specific geographic accessibility to transplant-capable services across Colombia and identifies populations living beyond clinically relevant travel-time thresholds to support transplant-network planning and identify underserved areas.
Retinopathy of prematurity and health economics
This study compares the cost-effectiveness of bevacizumab and ranibizumab for treatment-requiring retinopathy of prematurity using multicenter real-world clinical and economic data.
Observed retreatment after bevacizumab and ranibizumab, respectively.
Incremental net value favoring bevacizumab at the study threshold.
Share of probabilistic simulations favoring bevacizumab.
Critical care access and health-system planning
Principal investigators: Dr. Joseph L. Nates · Dr. Agamenón Quintero Villarreal · Jorge Racedo
This study evaluates population-level travel-time access to intensive-care services across Colombia and identifies areas with prolonged geographic access to inform critical-care policy, service planning, and network design.
Retinopathy of prematurity workforce and access
This study characterizes the distribution of the retinopathy of prematurity workforce in Colombia, evaluates geographic accessibility to care, and examines emerging practice patterns to identify gaps relevant to national service planning.
Obstetric critical care
Principal investigators: Dr. Joseph L. Nates · Jorge Racedo
A systematic review examining mortality prediction models in critically ill obstetric patients and assessing risk of bias in the underlying studies.
Obstetric critical care
Principal investigators: Dr. Francisco Camargo-Assis
This study evaluates rural–urban differences in obstetric intensive-care admission, organ support, resource use, and maternal–fetal outcomes within a Colombian hospital cohort from 2014 through 2018.
Health economics and decision science
This methodological study evaluates the empirical stability of the incremental cost-effectiveness ratio relative to net monetary benefit under probabilistic uncertainty, examining which metric communicates decision uncertainty more reliably.
Artificial intelligence and biomedical engineering
An investigational AI pathway supports neonatologists, neonatal nurses, general practitioners and other primary-care staff in flagging suspected ROP and referring infants promptly to pediatric ophthalmologists, retina/vitreous specialists or other clinicians trained in ROP. The AI does not diagnose ROP; specialist assessment and routine surveillance remain essential.
PUBLISHED BOOK CHAPTERS · CRITICAL CARE
A published Springer contribution on electrolyte disorders in critically ill patients with cancer. Each chapter is linked to its publisher record and shown here as scholarly output—not as a standalone clinical recommendation.
Published microscopIA affiliation: Department of Health Systems Engineering and Global Health, microscopIA, Bogotá, Colombia.
Oncologic Critical Care · Springer Nature · DOI: 10.1007/978-3-319-74698-2_84-2
Oncologic Critical Care · Springer Nature · DOI: 10.1007/978-3-319-74698-2_85-2
Oncologic Critical Care · Springer Nature · DOI: 10.1007/978-3-319-74698-2_86-2
Oncologic Critical Care · Springer Nature · DOI: 10.1007/978-3-319-74698-2_87-2
Oncologic Critical Care · Springer Nature · DOI: 10.1007/978-3-319-74698-2_88-2